Cost Evaluation of Current Pulmonary MTB Diagnosis Process in a Hospital in Abu Dhabi and Proposal to Implement the World Health Organization MTB Clinical Pathway

Aim:Mycobacterium tuberculosis (MTB) is a leading cause of death worldwide. The World Health Organization (WHO) recommends X-pert MTB/RIF or X-pert Ultra as the initial test for pulmonary MTB diagnosis. While several studies have explored the cost-effectiveness of this technology, none have specific...

Full description

Bibliographic Details
Published in:	Eurasian Journal of Emergency Medicine
Main Authors:	Ward Ghaleb, Yamama Aljishi, Sanjay Ayathan, Ayesha Almemari
Format:	Article
Language:	English
Published:	Emergency Medicine Physicians’ Association of Turkey 2023-06-01
Subjects:	pulmonary mtb emergency department cost evaluation mycobacterium tuberculosis who clinical pathway x-pert mtb/rif afb smear
Online Access:	http://eajem.com/archives/archive-detail/article-preview/cost-evaluation-of-current-pulmonary-mtb-diagnosis/60681

Similar Items

Diagnostic Performance of Xpert MTB/RIF Ultra Compared with Predecessor Test, Xpert MTB/RIF, in a Low TB Incidence Setting: a Retrospective Service Evaluation
by: Mary Mansfield, et al.
Published: (2022-06-01)

Evaluation of Xpert MTB/RIF Assay, MTB Culture and Line Probe Assay for the Detection of MDR Tuberculosis in AFB Smear Negative Specimens
by: Chandri Lama, et al.
Published: (2022-10-01)

Multi-centric evaluation of Truenat MTB and MTB-RIF Dx assays for diagnosis of extrapulmonary tuberculosis
by: Urvashi B. Singh, et al.
Published: (2024-07-01)

The diagnostic performance of endobronchial ultrasound with Xpert MTB/RIF Ultra in smear-negative pulmonary tuberculosis
by: Lan Yao, et al.
Published: (2023-02-01)

The Magnitude of MTB and Rifampicin Resistance MTB Using Xpert-MTB/RIF Assay Among Tuberculosis Suspected Patients in Gedeo Zone, Southern Ethiopia
by: Diriba K, et al.
Published: (2021-09-01)

Implementation of the Xpert MTB/RIF assay for tuberculosis in Mongolia: a qualitative exploration of barriers and enablers
by: Nicole L. Rendell, et al.
Published: (2017-07-01)

Sequential testing with Xpert MTB/RIF assay for diagnosis of tuberculous meningitis in Maharaj Nakorn Chiang Mai University Hospital
by: Poramed Winichakoon, et al.
Published: (2025-01-01)

Analysis of unsuccessful tests and the effect of prolonged clinical sample preprocessing in the GeneXpert MTB/RIF assay
by: Jian-Hao Wei, et al.
Published: (2024-08-01)

Xpert MTB/RIF for rapid detection of rifampicin-resistant Mycobacterium tuberculosis from pulmonary tuberculosis patients in Southwest Ethiopia
by: Mulualem Tadesse, et al.
Published: (2016-01-01)

Utility of Xpert MTB/RIF Assay for Diagnosis of Pediatric Tuberculosis Under Programmatic Conditions in India
by: Rakesh Yadav, et al.
Published: (2020-01-01)

Comparison of targeted next-generation sequencing and the Xpert MTB/RIF assay for detection of Mycobacterium tuberculosis in clinical isolates and sputum specimens
by: Hongtai Zhang, et al.
Published: (2024-05-01)

Role of Culture Free Rapid ImmunoAssay (ELISA) and Genexpert (MTB/RIF) Technology in the Diagnosis of Tuberculosis
by: Shahida Hussain, et al.
Published: (2024-01-01)

Role of Culture Free Rapid ImmunoAssay (ELISA) and Genexpert (MTB/RIF) Technology in the Diagnosis of Tuberculosis
by: Shahida Hussain, et al.
Published: (2024-01-01)

Evaluation of the Xpert MTB/RIF Test Performance in the Diagnosis of Suspected M. tuberculosis in Pulmonary and Extrapulmonary Clinical Specimens
by: Hüseyin Agah TERZİ, et al.
Published: (2024-10-01)

Comparison of microscopic and xpert MTB diagnoses of presumptive mycobacteria tuberculosis infection: retrospective analysis of routine diagnosis at Cape Coast Teaching Hospital
by: Kwame Kumi Asare, et al.
Published: (2024-07-01)

Positivity Proportion of Xpert MTB/RIF in Suspected Pediatric Pulmonary Tuberculosis Patients at Dr. Soetomo General Academic Hospital, Surabaya, Indonesia
by: Sabila Salsabila, et al.
Published: (2025-08-01)

Rolling out Xpert MTB/RIF® for tuberculosis detection in HIV-positive populations: An opportunity for systems strengthening
by: Ishani Pathmanathan, et al.
Published: (2017-03-01)

Performance of Xpert MTB/RIF ultra for the diagnosis of tuberculous meningitis in children using cerebrospinal fluid
by: S. M. Mazidur Rahman, et al.
Published: (2025-04-01)

Xpert MTB/RIF Ultra outperformed the Xpert assay in tuberculosis lymphadenitis diagnosis: a prospective head-to-head cohort study
by: Xia Yu, et al.
Published: (2022-09-01)

Diagnostic value of tNGS vs Xpert MTB/RIF in childhood TB
by: Huiwen Zheng, et al.
Published: (2024-01-01)

Performance of stool-based Xpert MTB/RIF assay in the diagnosis of presumptive pulmonary tuberculosis in adults unable to expectorate sputum
by: Yi Xue, et al.
Published: (2025-04-01)

CHARACTERISTICS AND EFFICIENCY OF TREATMENT IN TUBERCULOSIS PATIENTS DEPENDING ON THE ХPERT MTB/RIF RESULTS
by: A. M. MАLIK
Published: (2017-10-01)

CRISPR-based rapid and ultra-sensitive diagnostic test for Mycobacterium tuberculosis
by: Jing-Wen Ai, et al.
Published: (2019-01-01)

Phenotypic drug susceptibility characterization and clinical outcomes of tuberculosis strains with A-probe mutation by GeneXpert MTB/RIF
by: Qi Nie, et al.
Published: (2023-11-01)

Tuberculosis reinfection in a pregnant cystic fibrosis patient
by: Asween Marco, et al.
Published: (2015-01-01)

Comparison between TRCReady MTB and MTB ELITe MGB kit for the direct detection of Mycobacterium tuberculosis complex in respiratory and non-respiratory samples
by: Arianna Gatti, et al.
Published: (2017-07-01)

Efficacy of Xpert MTB/RIF assay in detecting Mycobacterium tuberculosis in samples with different results by smear and culture in a coastal city with high incidence of tuberculosis
by: Gang Feng, et al.
Published: (2025-01-01)

The role of Xpert MTB/RIF using bronchoalveolar lavage fluid in active screening: insights from a tuberculosis outbreak in a junior school in eastern China
by: Qian Wu, et al.
Published: (2023-12-01)

Mycobacterium tuberculosis Detection in Diverse Clinical Specimens by GeneXpert MTB/RIF: A Large-Scale Retrospective Study
by: Li H, et al.
Published: (2025-05-01)

Evaluación del rendimiento del ensayo GeneXpert MTB/RIF en muestras con sospecha de tuberculosis extrapulmonar recibidas en el C.H.DR.A.A.M. de enero 2020-diciembre 2021
by: Oneira T. Riquelme, et al.
Published: (2023-06-01)

Evaluación del rendimiento del ensayo GeneXpert MTB/RIF en muestras con sospecha de tuberculosis extrapulmonar recibidas en el C.H.DR.A.A.M. de enero 2020-diciembre 2021
by: Oneira T. Riquelme, et al.
Published: (2023-06-01)

Evaluation of in-house loop-mediated isothermal amplification for tuberculosis diagnosis compared with Xpert MTB/RIF
by: Charity Habeenzu, et al.
Published: (2017-06-01)

A case of tuberculous pericardial effusion confirmed by GeneXpert MTB/RIF combined with literature review
by: PENG Rong, LI Mu, MA Kuo, GONG Qian
Published: (2023-06-01)

Change in TB diagnostic profile after introduction of GeneXpert MTB/RIF assay in National TB Program of Armenia, 2013-2017
by: Eduard Kabasakalyan, et al.
Published: (2019-05-01)

Construction and application of a heterogeneous quality control library for the Xpert MTB/RIF assay in tuberculosis diagnosis
by: Zehao Guan, et al.
Published: (2023-03-01)

Incremental detection of pulmonary tuberculosis among presumptive patients by GeneXpert MTB/RIF® over fluorescent microscopy in Mwanza, Tanzania: an operational study
by: Jeremiah Seni, et al.
Published: (2015-06-01)

Accuracy of Nanopore Sequencing as a Diagnostic Assay for Pulmonary Tuberculosis versus Smear, Culture and Xpert MTB/RIF: A Head-to-Head Comparison
by: Juan Yang, et al.
Published: (2023-09-01)

Trend of pulmonary tuberculosis and rifampicin-resistance among tuberculosis presumptive patients in Central Tigray, Ethiopia; 2018 -2023: a six-year retrospective study
by: Guesh Gebremariam, et al.
Published: (2024-07-01)

Difficulties with the implemented xpert MTB/RIF for determining diagnosis of pulmonary and extrapulmonary tuberculosis in adults and children
by: Ni Made Mertaniasih, et al.
Published: (2020-05-01)

Comprehensive assessment of invalid and indeterminate results in Truenat MTB-RIF testing across sites under the national TB elimination program of India
by: Radha Gopalaswamy, et al.
Published: (2023-10-01)